Franklin Resources
ELTX icon

Franklin Resources’s Elicio Therapeutics ELTX Stock Holding History

Franklin Resources’s Portfolio ELTX Stock Details ELTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-61,526
Closed -$6.01M – 2495
2021
Q3 		$6.01M Buy
61,526
+26
+0% +$2.81K ﹤0.01% 1163
2021
Q2 		$8.01M Hold
61,500
– – ﹤0.01% 1048
2021
Q1 		$11.1M Buy
+61,500
New +$11.9M ﹤0.01% 955

Other funds holding ELTX

NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Franklin Resources's ELTX Position: Q4 2021 in Review

Franklin Resources sold out of Elicio Therapeutics (ELTX) in Q4 2021, closing a stake of 61,526 shares — an estimated $6.01M sold.

Franklin Resources first reported a position in ELTX in Q1 2021 and held it in 3 quarters. The position peaked at $11.1M in Q1 2021. 53 funds tracked by Wall St. Rank hold ELTX as of Q4 2021.

  • Franklin Resources reported no remaining Elicio Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Franklin Resources sold 61,526 Elicio Therapeutics shares in Q4 2021, an estimated $6.01M.
  • Franklin Resources first reported a position in Elicio Therapeutics in Q1 2021 and held it in 3 quarters.
  • Franklin Resources's Elicio Therapeutics position peaked at $11.1M in Q1 2021.
  • 53 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q4 2021.

Based on Franklin Resources's 13F filing for Q4 2021, filed 11 Feb 2022.